An early effect of dysregulated cancer growth is the accumulation of malignant cells in excess of the physiological numbers that can be supported by the existing vascular system. As a result, developing tumors are subject to a combination of oxygen limitation and nutrient deprivation. Under such conditions, the accumulation of non-transformed cells is limited because hypoxia and/or nutrient depletion leads to the initiation of apoptosis. In contrast, most tumor cells are defective in their apoptotic response and, as a result, fail to respond to hypoxia and/or nutrient limitations through apoptosis. The goal of this project is to identify metabolic pathways that allow tumor cells to adapt and grow under conditions of nutrient and/or oxygen limitation.
Two Specific Aims are envisioned. In the first Specific Aim, we will examine the regulation of lipid synthesis and degradation under conditions of glucose depletion. In this Aim, we hope to gain insight into how tumor cells growing under glucose limitation can simultaneously activate fatty acid oxidation to support ATP production while maintaining the net fatty acid synthesis required for cell growth. Engaging in the simultaneous synthesis and catabolism of fatty acids puts the cell at risk of engaging in a potentially fatal futile cycle. In the second Specific Aim, we hope to determine the metabolic adaptations that support hypoxic cell survival and lipid synthesis. We will investigate how hypoxic tumor cells maintain viability and lipid synthesis despite the fact that HIF-1 a activation results in diversion of available glucose into anaerobic glycolysis. The studies of Specific Aim 1 should provide information that will contribute to the success of Projects 2 and 3. The proposed studies will provide insights into the molecular mechanisms by which cells maintain a viable ATP/ADP ratio while maintaining macromolecular synthesis under suboptimal conditions of glucose availability. In turn, the success of the studies proposed in Specific Aim 2 are dependent in part on the expertise and reagents available from Projects 2 and 3, and are also likely to benefit from insights derived from the ongoing results of these projects. Through these collaborative studies, we wish to gain insight into how both transformed and non-transformed cells not only survive but grow under conditions of oxygen and/or nutrient deprivation. As a result of the proposed investigations, we hope to identify ways to impair/augment these survival strategies to enhance the efficacy of existing cancer therapy while preserving the survival and recovery of non-transformed cells.

Public Health Relevance

Growing cells depend on higher levels of nutrient and oxygen utilization than quiescent cells, yet cancer cells are able to survive and continue to proliferate under conditions of nutrient depletion and hypoxia that would otherwise result in the apoptotic cell death of non-transformed cells. In this project we propose to identify the pathways cancer cells utilize to survive and grow in the face of non-physiologic levels of oxygen or nutrients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA104838-10
Application #
8539276
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
10
Fiscal Year
2013
Total Cost
$340,006
Indirect Cost
$125,197
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Rozpedek, W; Pytel, D; Mucha, B et al. (2016) The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. Curr Mol Med 16:533-44
Krishna, Shefali; Palm, Wilhelm; Lee, Yongchan et al. (2016) PIKfyve Regulates Vacuole Maturation and Nutrient Recovery following Engulfment. Dev Cell 38:536-47
Tschaharganeh, Darjus F; Lowe, Scott W; Garippa, Ralph J et al. (2016) Using CRISPR/Cas to study gene function and model disease in vivo. FEBS J 283:3194-203
Pavlova, Natalya N; Thompson, Craig B (2016) The Emerging Hallmarks of Cancer Metabolism. Cell Metab 23:27-47
Xu, Zhenhua; Bu, Yiwen; Chitnis, Nilesh et al. (2016) miR-216b regulation of c-Jun mediates GADD153/CHOP-dependent apoptosis. Nat Commun 7:11422
Pytel, D; Majsterek, I; Diehl, J A (2016) Tumor progression and the different faces of the PERK kinase. Oncogene 35:1207-15
Gade, Terence P F; Hunt, Stephen J; Harrison, Neil et al. (2015) Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma. J Vasc Interv Radiol 26:1229-37
Qiu, Bo; Ackerman, Daniel; Sanchez, Danielle J et al. (2015) HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. Cancer Discov 5:652-67
Ye, Jiangbin; Palm, Wilhelm; Peng, Min et al. (2015) GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev 29:2331-6
Mucaj, V; Lee, S S; Skuli, N et al. (2015) MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma. Oncogene 34:2204-14

Showing the most recent 10 out of 93 publications